Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates

In December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19) was first identified in the province of Wuhan, China. Since then, there have been over 400 million confirmed cases and 5.8 million deaths by COVID-19 r...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Liliana, Bento Cunha, Renata, Vassilevskaia, Tatiana, Viveiros, Miguel, Cunha, Celso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099573/
https://www.ncbi.nlm.nih.gov/pubmed/35566073
http://dx.doi.org/10.3390/molecules27092723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099573/
https://www.ncbi.nlm.nih.gov/pubmed/35566073
http://dx.doi.org/10.3390/molecules27092723

Ejemplares similares